Lupin gets US FDA nod to market postherpetic neuralgia drug
The company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cadila gets five observations from US FDA
The inspection was conducted at its subsidiary Liva Pharmaceuticals' injectables manufacturing facility in Vadodara
Suven secures product patents in China, Eurasia
The granted claims of the patents are being developed as therapeutic agents useful in the treatment of cognitive impairment…
Glenmark to market Tiotropium Bromide dry powder inhaler in Western Europe
Tiotropium Bromide DPI is a generic version of Boehringer Ingelheim's Spiriva Handihaler
Novartis wins EU approval for blood cancer therapy Kymriah
Novartis is investing 90 million Swiss francs ($90.4 million) in a new Swiss facility to produce Kymriah
Pfizer’s tafamidis reduces risk of death by 30 %, reveals study
The data was presented at the European Society of Cardiology Congress in Munich
Making it future ready
On Teachers’ Day, experts comment on ways to improve pharmacy education in the country
Build excitement in the learning process | Dr B Suresh
From time immemorial medicinal plants have been the source of many new drugs and the discovery of new molecules. With the…
Need to re-engineer pharmacognosy science | Dr Swarnlata Saraf
The pharmacognosy branch of pharmaceutical sciences can remain in the pharmacy profession with re-engineering the contents…
The subject is essential for pharma science | Dr N Udupa
Pharmacognosy subject is an essential area for the development of pharmaceutical sciences. Along with pharmacology,…